Eli Lilly’s weight-loss drug no longer in shortage, FDA says
Eli Lilly’s weight-loss drug no longer in shortage, FDA says View original article Contributor: Hannah Ziegler, Daniel Gilbert
Eli Lilly’s weight-loss drug no longer in shortage, FDA says View original article Contributor: Hannah Ziegler, Daniel Gilbert
While more than 25 million Americans have lost Medicaid coverage during the Medicaid “unwinding,” many also gained coverage. View original article Contributor: Phil Galewitz, McKenzie Beard
Oct. 2 (UPI) — The search for more affordable medications might cause people to access dangerous counterfeit drugs sold as genuine products by online pharmacies, the Centers for Disease Control … Click to Continue » View original article Contributor:
Many middle-income countries are left out of the deal, widening a gulf in access to critical medicines. View original article Contributor: Stephanie Nolen
The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped. View original article Contributor: Teddy Rosenbluth
Integrative Medicine in Neuro-oncology: Virtual Group Visits Medscape >View original article Contributor:
The short but much-loved life of a French bulldog named George leaves a legacy of learning for those who care for animals and humans. George’s owner Louis Tavares, of Windemere, … Click to Continue » View original article Contributor:
One in 14 hospital patients may be the victim of damaging diagnostic mistakes, new research suggests. The finding is from a study of 675 patients admitted to one large hospital … Click to Continue » View original article Contributor:
Want to keep a stroke a bay? Drink water, nothing fizzy and skip fruit drinks. That’s the key takeaway from a global review that also raises a red flag for … Click to Continue » View original article Contributor:
NEW YORK, Oct. 2 (UPI) — Bright-light therapy offers major advantages as an addition to treatment with antidepressants for non-seasonal depressive disorders, a new analysis of 11 randomized clinical trials … Click to Continue » View original article Contributor: